Literature DB >> 2030746

Effects of the calmodulin antagonists fendiline and calmidazolium on aggregation, secretion of ATP, and internal calcium in washed human platelets.

A Lückhoff1, M Bohnert, R Busse.   

Abstract

Ca2(+)-calmodulin dependent phosphorylation of myosin is essential for the induction of platelet shape change and subsequent reactions. Therefore, we studied the effects of the calmodulin antagonists fendiline and calmidazolium on the thrombin-induced aggregation, secretion of ATP, and increases in the intracellular free calcium concentration ([Ca2+]i) in washed human platelets in the absence and presence of extracellular Ca2+. In Ca2+ free medium, fendiline (10-100 microM) and calmidazolium (3-30 microM) concentration-dependently inhibited aggregation. The effect of fendiline could be partly reversed by extracellular Ca2+ and higher thrombin concentrations. Furthermore, aggregations induced by the calcium ionophore ionomycin and by the protein kinase C-activator 4-beta-phorbol 12-myristate 13-acetate were inhibited by fendiline, although to a smaller degree than the thrombin-induced aggregation. Thrombin-induced secretion of ATP was attenuated by low concentrations of fendiline (1-3 microM) and calmidazolium (1 microM) but enhanced by higher concentrations (10-30 and 3-10 microM, respectively), independently of extracellular Ca2+. Fendiline (1-10 microM) did not affect [Ca2+]i in resting and thrombin-stimulated platelets. At higher concentrations (30-100 microM), it induced increases in [Ca2+]i in unstimulated platelets and attenuated the response to thrombin in Ca2+ free medium, whereas thrombin-induced Ca2+ influx was markedly enhanced. Similar results were obtained with calmidazolium (1-3 microM). These stimulating effects on ATP secretion and on [Ca2+]i of fendiline and calmidazolium may be attributed to interactions with platelet membranes by which the permeability of small cations is increased.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2030746     DOI: 10.1007/bf00180683

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  Interaction of calmodulin with the calmodulin binding domain of the plasma membrane Ca2+ pump.

Authors:  T Vorherr; P James; J Krebs; A Enyedi; D J McCormick; J T Penniston; E Carafoli
Journal:  Biochemistry       Date:  1990-01-16       Impact factor: 3.162

Review 2.  Molecular mechanisms of platelet activation.

Authors:  W Siess
Journal:  Physiol Rev       Date:  1989-01       Impact factor: 37.312

3.  Endothelium-derived relaxant factor inhibits platelet activation.

Authors:  R Busse; A Lückhoff; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

4.  R 24571: a new powerful inhibitor of red blood cell Ca++-transport ATPase and of calmodulin-regulated functions.

Authors:  K Gietzen; A Wüthrich; H Bader
Journal:  Biochem Biophys Res Commun       Date:  1981-07-30       Impact factor: 3.575

5.  The effects of nifedipine, a calcium antagonist, on platelet function.

Authors:  J Dale; K H Landmark; E Myhre
Journal:  Am Heart J       Date:  1983-01       Impact factor: 4.749

6.  Effects of the calmodulin antagonist trifluoperazine on stimulus-induced calcium mobilization, aggregation, secretion, and protein phosphorylation in platelets.

Authors:  M B Feinstein; R A Hadjian
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

7.  LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation.

Authors:  A Mülsch; A Lückhoff; U Pohl; R Busse; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

8.  Purification and reconstitution of a Ca2+ pump from human platelets.

Authors:  W L Dean
Journal:  J Biol Chem       Date:  1984-06-10       Impact factor: 5.157

9.  Diacylglycerol and phorbol ester stimulate secretion without raising cytoplasmic free calcium in human platelets.

Authors:  T J Rink; A Sanchez; T J Hallam
Journal:  Nature       Date:  1983 Sep 22-28       Impact factor: 49.962

10.  Effects of nifedipine (Adalat) on platelet function in vitro and in vivo.

Authors:  H Johnsson
Journal:  Thromb Res       Date:  1981 Feb 15-Mar 1       Impact factor: 3.944

View more
  3 in total

1.  Identification, Quantification, and System Analysis of Protein N-ε Lysine Methylation in Anucleate Blood Platelets.

Authors:  Anne D Rocheleau; Alexander R Melrose; Jennifer M Cunliffe; John Klimek; Özgün Babur; Samuel Tassi Yunga; Anh T P Ngo; Jiaqing Pang; Larry L David; Owen J T McCarty; Joseph E Aslan
Journal:  Proteomics       Date:  2019-05-09       Impact factor: 3.984

Review 2.  Clinical potential of GABAB receptor modulators.

Authors:  Jennifer Ong; David I B Kerr
Journal:  CNS Drug Rev       Date:  2005

3.  Calmidazolium and arachidonate activate a calcium entry pathway that is distinct from store-operated calcium influx in HeLa cells.

Authors:  Claire M Peppiatt; Anthony M Holmes; Jeong T Seo; Martin D Bootman; Tony J Collins; Fraser McDonald; H Llewelyn Roderick
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.